Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 04/23 02:19:11 pm
304.6 USD   -2.27%
2d ago Studies find new drugs greatly lower cholesterol
04/16 NASDAQ 100 MOVERS : Lltc, yhoo
04/14 REGENERON PHARMACEUTICALS : Yale University Assigned Patent
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
Recommend:
0
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
Recommend :
0
React to this article
Latest news on REGENERON PHARMACEUTICALS
2d ago Studies find new drugs greatly lower cholesterol
04/16 NASDAQ 100 MOVERS : Lltc, yhoo
04/14 REGENERON PHARMACEUTICALS : Yale University Assigned Patent
04/11 REGENERON PHARMACEUTICALS : to Report First Quarter 2014 Financial and Operating..
04/10 REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Report Positive Results With ..
04/10 REGENERON PHARMACEUTICALS : Announces Initiative for STEM Education in Hudson Va..
04/09 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
04/09 NASDAQ 100 MOVERS : Isrg, regn
04/08 REGENERON PHARMACEUTICALS : Introduces Initiative for STEM Education in Hudson V..
04/08 REGENERON PHARMACEUTICALS : Launches Initiative for STEM Education in Hudson Val..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF